February 22, 2017
Masato Iwasaki, President, Japan Pharma Business Unit, Takeda Pharmaceutical Takeda Pharmaceutical is ramping up its efforts to respond to the Japanese government’s initiative to create community-based integrated care systems by 2025, assigning high-caliber former sales reps to collect information on...read more